Clinical Trials Logo

Clinical Trial Summary

Recent advances in neonatal intensive care have dramatically increased the survival rate of extremely premature infants but the number of survivors with severe morbidity and lifelong neurodevelopmental impairment remains high. Perinatal white matter injury is the predominant form of brain injury in premature infants, often leading to adverse neurodevelopmental outcome. Intrauterine and neonatal infection and inflammation have been identified as major risk factors of neonatal brain injury. The fragile gut microbiome of premature infants seems to play an important role in health and disease as distortions of the microbiome occur prior to sepsis and necrotizing enterocolitis. Furthermore, the close link of the gut microbiome to neurological and psychiatric diseases in animal models suggests that the microbiome may influence brain maturation and development in preterm infants. Recent studies have underlined the importance of regulatory T cells as well as γδ T cells in brain injury, which can be directly influenced by the gut microbiome. It is therefore likely that an underdeveloped or distorted gut microbiome affects host immune response and may be a risk factor for neurodevelopmental disabilities in extremely premature infants who are already challenged by the unphysiologic early extrauterine environment after premature birth which affects maturation of the gut microbiome and immune system as well as neurophysiological maturation alike.

Therefore, the overarching aim of the PreMiBraIn study is to elucidate the role of the gut-immune-brain axis on neonatal brain injury and its impact on long-term neurodevelopmental outcome of extremely premature infants. The study cohort will consist of a total of 60 extremely premature infants with a gestational age < 28 weeks and birth weight < 1000 grams. The investigators seek to characterize the orchestrated dynamics of the maturation of the gut microbiome and the subsequent impact on maturation of innate and adaptive immune mechanisms as well as neurophysiological maturation and neurodevelopmental outcome. Furthermore, the investigators will assess the value of the microbiome as a prognostic indicator for neonatal brain injury as well as short- and long-term neurodevelopmental outcome of extremely premature infants.

This goal will be achieved by state-of-the-art techniques using 16s rRNA gene sequencing of the gut microbiome, holistic analysis of T cell biology using flow cytometry, whole transcriptome analysis and proteomics as well as neurophysiological measurements (amplitude-integrated EEG, near-infrared spectroscopy, visual evoked potentials) and cranial MRI of extremely premature infants. Short- and long-term neurological outcome will be investigated using Bayley Scales of Infant Development, Third Edition at one and two years corrected age, and Kaufmann-Assessment Battery for Children at five years of age. The investigators expect to find microbiome signatures that are predictive for later neurodevelopmental disabilities which may then be used for early screening and intervention and may suggest personalized therapeutic options. The prospects of precision medicine targeting the gut-immune-brain axis in extremely premature infants hold the opportunity to improve the overall outcome of these high-risk patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03213275
Study type Observational
Source Medical University of Vienna
Contact
Status Active, not recruiting
Phase
Start date October 11, 2017
Completion date August 28, 2025

See also
  Status Clinical Trial Phase
Active, not recruiting NCT03586622 - One Year Home Monitoring and Treatment of IBS Patients N/A
Active, not recruiting NCT04552834 - Alterations of the Microbiome During Critical Illness With Short and Long Term Clinical Outcomes
Completed NCT03201068 - Probiotic Supplement and Microbiome, Immune System and Metabolic Syndrome N/A
Completed NCT04217122 - Effect of Strawberry Consumption on the Microbiome N/A
Recruiting NCT05521295 - Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome
Recruiting NCT05545631 - Frozen Embryo Transfer Pregnancy Outcomes Prediction by Microbiome and Transcriptome
Not yet recruiting NCT05852145 - Oral Changes With Caloric and no Caloric Sweeteners Phase 1/Phase 2
Withdrawn NCT04099446 - A Non-Interventional Pilot Study to Explore the Skin Microbes in Skin Cancer
Recruiting NCT05445544 - A Multicenter Cohort Study on Maternal and Infant Microecology and New Targets for Pre-eclampsia Screening in China
Recruiting NCT05505110 - MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing N/A
Completed NCT04851340 - Investigating the Detection of Bovine and Soy Proteins in Human Milk N/A
Completed NCT06133400 - Mapping the Health Status of the Population of French Polynesia: the MATAEA Project N/A
Withdrawn NCT04114513 - Dietary Fibers Effect on the Gut Microbiota Composition N/A
Not yet recruiting NCT05612620 - Elucidating the Microbiome in Patients With Recurrent Pregnancy Loss
Completed NCT04611945 - Westlake Sailing Cohort
Recruiting NCT04260295 - Study of the Correlation of Tumor Tissue Microbiome to the Pathogenesis of Lung Cancer
Completed NCT04155684 - Dysbiosis Impact on Lung Disease in HIV
Active, not recruiting NCT06424691 - Infant Restore: Efficacy of Microbiome Analysis and Education N/A
Completed NCT05510050 - Comparison Study of Manapol and DaltonMax on Immune Function, Microbiome, and Related Variables in Men and Women N/A
Recruiting NCT04865861 - The Characteristic of Airway Microbiome Profiling of COPD-bronchiectasis Overlap Patients and Its Association With Acute Exacerbation